Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Howroyd, P.
Right arrow Articles by Hardisty, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howroyd, P.
Right arrow Articles by Hardisty, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Apparent Alveolar Bronchiolar Tumors Arising in the Mediastinum of F344 Rats

Paul Howroyd1,2, Neil Allison1,3, Julie F. Foley4 and Jerry Hardisty1

1 Experimental Pathology Laboratories, Inc., Research Triangle Park, North Carolina, USA
2 MDS Pharma Services, Les Oncins, France
3 Experimental Pathology Laboratories, Inc., National Toxicology Program Archives, Research Triangle Park, North Carolina, USA
4 Cellular and Molecular Pathology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA

Correspondence: Neil Allison, Experimental Pathology Laboratories, Inc., National Toxicology Program Archives, P.O. Box 13566, Research Triangle Park, NC 27709; e-mail:nallison{at}epl-inc.com.

Rare tumors were observed in chronic studies in F-344 rats that were purely or largely free in the mediastinal cavity, yet had the histological architecture of alveolar bronchiolar tumors. They had originally been diagnosed as either pulmonary alveolar bronchiolar tumors, mediastinal mesotheliomas, or thymomas. The authors described these tumors, estimated the fraction of thoracic tumors that they represented, and carried out a preliminary immunohistochemical investigation of whether they were of pulmonary or mesothelial origin. Sections of 715 thoracic tumors originally diagnosed as alveolar bronchiolar tumors, mesotheliomas, or thymomas from control or treated F-344 rats in NTP two-year studies were reviewed. Thirty (4%) were found to be purely or largely mediastinal, yet to have an alveolar bronchiolar histological pattern. A subset of these tumors and some typical intrapulmonary alveolar bronchiolar carcinomas and pleural mesotheliomas were immunostained for Clara cell secretory protein (CCSP), β-tubulin IV, and Wilm’s tumor 1 susceptibility gene products (WT1). The tumors with the histological architecture of alveolar bronchiolar tumors immunostained positive for CCSP and negative for WT1, implying they might have been of alveolar bronchiolar origin, despite their predominantly mediastinal location, although more certain identification would require the use of a larger panel of antibodies.

Key Words: rat • carcinogenicity • lung • mediastinum • alveolar bronchiolar carcinoma • mesothelioma • immunohistochemistry

Abbreviations: CCSP (CC-10), Clara cell secretory 10-kd protein • CEA, carcinoembryonic antigen • NTP, National Toxicology Program • SP-A, surfactant protein A • WT-1, Wilm’s tumor 1 susceptibility gene products

Toxicologic Pathology, Vol. 37, No. 3, 351-358 (2009)
DOI: 10.1177/0192623309332988


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?